Quarterly Accounts Receivable
$0.00
$0.000.00%
30 September 2023
Summary:
NeuBase Therapeutics quarterly accounts receivable is currently $0.00, unchanged on 30 September 2023.NBSE Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBSE Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NBSE Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -100.0% |
NeuBase Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | - | $150.00 K(+426.3%) |
| June 2014 | - | $28.50 K |
FAQ
- What is NeuBase Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for NeuBase Therapeutics?
What is NeuBase Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of NBSE is $0.00
What is the all time high quarterly accounts receivable for NeuBase Therapeutics?
NeuBase Therapeutics all-time high quarterly accounts receivable is $150.00 K